Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injury

Acute kidney injury (AKI) resulting from ischemia-reperfusion injury (IRI) is a common challenge in various clinical practices, yet effective therapies remain elusive. Endothelial injury plays a crucial role in the pathogenesis of renal IRI. Endothelial progenitor cells (EPCs) derived extracellular...

Full description

Saved in:
Bibliographic Details
Main Authors: Di Wu, Wenjie Ma, Liucheng Wang, Chengcheng Long, Silin Chen, Jingyu Liu, Yiguan Qian, Jun Zhao, Changcheng Zhou, Ruipeng Jia
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006425000869
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557544971698176
author Di Wu
Wenjie Ma
Liucheng Wang
Chengcheng Long
Silin Chen
Jingyu Liu
Yiguan Qian
Jun Zhao
Changcheng Zhou
Ruipeng Jia
author_facet Di Wu
Wenjie Ma
Liucheng Wang
Chengcheng Long
Silin Chen
Jingyu Liu
Yiguan Qian
Jun Zhao
Changcheng Zhou
Ruipeng Jia
author_sort Di Wu
collection DOAJ
description Acute kidney injury (AKI) resulting from ischemia-reperfusion injury (IRI) is a common challenge in various clinical practices, yet effective therapies remain elusive. Endothelial injury plays a crucial role in the pathogenesis of renal IRI. Endothelial progenitor cells (EPCs) derived extracellular vesicles (EVs) hold promise as cell-free therapies for treating renal IRI; however, their efficacy is limited by low delivery efficiency. In this study, we developed neutrophils (NEs) membrane-modified EVs (N-EVs) by exploiting the natural properties of NEs to target damaged endothelium. N-EVs inherited the characteristic membrane proteins of NEs along with the biological functions of EPCs-EVs. Results from in vitro and in vivo experiments demonstrated that N-EVs significantly enhanced the targeting efficiency of EVs towards IRI kidneys via P-selectin glycoprotein ligand-1 (PSGL-1). Moreover, N-EVs effectively promoted the proliferation, migration, and tube-formation abilities of injured endothelial cells (ECs) and contributed to overall renal function improvement in IRI kidneys through targeted delivery of miR-21-5p. Additionally, N-EVs could restore damaged endothelial integrity, reduce cytokine release, and inhibit leukocyte infiltration, hence alleviating renal inflammation. In conclusion, our accessible engineering approach represents a promising strategy for treating renal IRI. Furthermore, this membrane hybrid modification can be tailored and optimized for broader applications in treating other diseases.
format Article
id doaj-art-c20256fd59a84dd09bec0a0247d293e8
institution Kabale University
issn 2590-0064
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj-art-c20256fd59a84dd09bec0a0247d293e82025-02-03T04:16:53ZengElsevierMaterials Today Bio2590-00642025-04-0131101528Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injuryDi Wu0Wenjie Ma1Liucheng Wang2Chengcheng Long3Silin Chen4Jingyu Liu5Yiguan Qian6Jun Zhao7Changcheng Zhou8Ruipeng Jia9Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, ChinaDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, ChinaDepartment of Urology, Lianshui People's Hospital, Kangda College Affiliated to Nanjing Medical University, Jiang Su, 223400, ChinaDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, ChinaDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, ChinaDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, ChinaDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, ChinaDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, ChinaDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China; Corresponding author. Department of Urology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China.Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, China; Corresponding author. Department of Urology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing, 210006, China.Acute kidney injury (AKI) resulting from ischemia-reperfusion injury (IRI) is a common challenge in various clinical practices, yet effective therapies remain elusive. Endothelial injury plays a crucial role in the pathogenesis of renal IRI. Endothelial progenitor cells (EPCs) derived extracellular vesicles (EVs) hold promise as cell-free therapies for treating renal IRI; however, their efficacy is limited by low delivery efficiency. In this study, we developed neutrophils (NEs) membrane-modified EVs (N-EVs) by exploiting the natural properties of NEs to target damaged endothelium. N-EVs inherited the characteristic membrane proteins of NEs along with the biological functions of EPCs-EVs. Results from in vitro and in vivo experiments demonstrated that N-EVs significantly enhanced the targeting efficiency of EVs towards IRI kidneys via P-selectin glycoprotein ligand-1 (PSGL-1). Moreover, N-EVs effectively promoted the proliferation, migration, and tube-formation abilities of injured endothelial cells (ECs) and contributed to overall renal function improvement in IRI kidneys through targeted delivery of miR-21-5p. Additionally, N-EVs could restore damaged endothelial integrity, reduce cytokine release, and inhibit leukocyte infiltration, hence alleviating renal inflammation. In conclusion, our accessible engineering approach represents a promising strategy for treating renal IRI. Furthermore, this membrane hybrid modification can be tailored and optimized for broader applications in treating other diseases.http://www.sciencedirect.com/science/article/pii/S2590006425000869EngineeringExtracellular vesicleNeutrophilCell membraneRenoprotectionmiRNAs
spellingShingle Di Wu
Wenjie Ma
Liucheng Wang
Chengcheng Long
Silin Chen
Jingyu Liu
Yiguan Qian
Jun Zhao
Changcheng Zhou
Ruipeng Jia
Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injury
Materials Today Bio
Engineering
Extracellular vesicle
Neutrophil
Cell membrane
Renoprotection
miRNAs
title Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injury
title_full Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injury
title_fullStr Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injury
title_full_unstemmed Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injury
title_short Physically engineered extracellular vesicles targeted delivering miR-21-5p to promote renoprotection after renal ischemia-reperfusion injury
title_sort physically engineered extracellular vesicles targeted delivering mir 21 5p to promote renoprotection after renal ischemia reperfusion injury
topic Engineering
Extracellular vesicle
Neutrophil
Cell membrane
Renoprotection
miRNAs
url http://www.sciencedirect.com/science/article/pii/S2590006425000869
work_keys_str_mv AT diwu physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury
AT wenjiema physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury
AT liuchengwang physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury
AT chengchenglong physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury
AT silinchen physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury
AT jingyuliu physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury
AT yiguanqian physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury
AT junzhao physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury
AT changchengzhou physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury
AT ruipengjia physicallyengineeredextracellularvesiclestargeteddeliveringmir215ptopromoterenoprotectionafterrenalischemiareperfusioninjury